Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds ...Middle East

JERUSALEM, Jan. 4, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company focused both on development of inflammation and immunology (I&I) biological therapeutic products and provision of boutique CDMO services, today announced the closing of its...

Hence then, the article about scinai immunotherapeutics announces closing of exercise of outstanding warrants for 1 69 million in gross proceeds was published today ( Friday 05/01/2024 - 12:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds )

Also on site :

• Gwyneth Paltrow Reveals Famous Ex-Boyfriend Introduced Her to Robin Williams Years After Their First Movie Together
• Zelensky’s ex-deputy chief of staff charged with ‘green’ energy scam
• The 50 Best 'Survivor' Challenges Ever — According to the People Who Made Them (Exclusive)